Autophagy and Lymphoma.

Abstract

Lymphoma is a hematological malignancy and its incidence is growing. The use of CD20 monoclonal antibody improves the therapeutic efficacy in CD20-positive B-cell lymphoma. Despite remarkable progress in lymphoma treatment over the past decades, chemotherapy resistance and disease relapse become the main obstacles to further improve the prognosis of the patients. Therefore, the development of new treatment methods and drugs is urgently needed to improve the treatment of lymphoma. In tumors, autophagy functions to protect tumor cells from hypoxia, radiotherapy, and apoptosis. The ability to improve the prognosis of patients with lymphoma through the active regulation of autophagy represents a new approach to clinical treatment.

• Authors: Zhong Zheng, Li Wang, Shu Cheng, Yan Wang, Weili Zhao
• Journal: Advances in experimental medicine and biology (Adv Exp Med Biol) Vol. 1207 Pg. 615-623 ( 2020) ISSN: 0065-2598 [Print] United States
• PMID: 32671779 (Publication Type: Journal Article, Review)

Topics

• Apoptosis
• Autophagy (drug effects)
• Humans
• Lymphoma (drug therapy)
• Lymphoma, B-Cell (drug therapy)